ACCORD HEALTHCARE, INC. Recalls

All product recalls associated with ACCORD HEALTHCARE, INC..

Get alerts for this brand

Recall Summary

Total Recalls

18

Past Year

12

Class I (Serious)

0

Most Recent

Sep 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–18 of 18 recalls

Levothyroxine Tablets (Accord) – Subpotent Medication (2025)

Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.

Stay Informed

ACCORD HEALTHCARE, INC. Recalls

Recall Summary

Levothyroxine Tablets (Accord) – Subpotent Medication (2025)

Levothyroxine Sodium Tablets 25mcg (Accord) – Subpotent Drug (2025)

Levothyroxine Sodium Tablets 100mcg (Accord) – Subpotent Drug (2025)

Levothyroxine Sodium Tablets 50mcg (Accord) – Subpotent Drug (2025)

Levothyroxine Sodium Tablets 150mcg (Accord) – Subpotent Drug (2025)

Levothyroxine Sodium Tablets 175mcg (Accord) – Subpotent Drug (2025)

Levothyroxine Sodium Tablets 112mcg (Accord) – Subpotent Drug (2025)

Levothyroxine Sodium Tablets 25mcg (Accord) – Subpotent Drug (2025)

Levothyroxine Sodium Tablets (Accord Healthcare) – Subpotent Medication (2025)

Levothyroxine 50mcg (ACCORD) – Subpotent (2025)

Levothyroxine 88mcg (ACCORD) – Subpotent (2025)

Levothyroxine Sodium Tablets (Accord Healthcare) – Subpotent Medication (2025)

Levothyroxine Sodium Tablets (Accord Healthcare) – Subpotent Drug (2024)

Cinacalcet Tablets 60mg (Accord) – Nitrosamine Impurity (2024)

Cinacalcet Tablets 30mg (Accord) – Nitrosamine Impurity (2024)

Cinacalcet Tablets 90mg (Accord) – Nitrosamine Impurity (2024)

Cisplatin Injection (Accord Healthcare) – Impurity Specifications (2024)

Dodex Injectable (Accord Healthcare) – Subpotent Drug (2024)